Skip to main content

Table 4 Factors associated with 90-day mortality by multivariate analysis among patients who were not intubated on the day of ICU admission

From: Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals

 

n

Univariate HR (95% CI)

P value

Multivariate HR (95% CI)

P value

Age, years

1491

 

 < 0.001

 

 < 0.001

   ≤ 75

 

 

 

  60—74

 

0.43 (0.33–0.56)

 

0.60 (0.41–0.89)

 

  40—59

 

0.20 (0.14–0.27)

 

0.38 (0.23–0.63)

 

   < 40

 

0.17 (0.09–0.34)

 

0.33 (0.10–1.14)

 

Genre, woman

1488

0.85 (0.65–1.10)

0.216

0.77 (0.52–1.15)

0.893

Body mass index, kg/m2

1370

 

0.254

 

0.072

   < 25

 

 

 

  25—29

 

0.95 (0.70–1.27)

 

0.92 (0.61–1.41)

 

  30—34

 

0.74 (0.52–1.06)

 

0.79 (0.48–1.28)

 

  35—39

 

0.67 (0.41–1.08)

 

0.40 (0.18–0.86)

 

   ≥ 40

 

0.97 (0.53–1.75)

 

1.01 (0.45–2.28)

 

SAPS II score

1398

1.04 (1.03–1.05)

 < 0.001

1.03 (1.01–1.04)

 < 0.001

Treated hypertension

1485

1.45 (1.16–1.82)

 < 0.001

0.78 (0.54–1.11)

0.844

Known diabetes

1486

1.76 (1.40–2.21)

 < 0.001

1.28 (0.88–1.86)

0.015

Immunodepressiona

1479

2.21 (1.58–3.10)

 < 0.001

1.08 (0.60–1.92)

0.461

Frailty score

1379

 

 < 0.001

 

 < 0.001

  1–3

 

 

 

  4

 

3.18 (2.34–4.33)

 

2.22 (1.39–3.54)

 

  5–9

 

4.23 (3.02–5.92)

 

1.67 (0.92–3.04)

 

Delay between first signs and ICU admission, days

1424

 

 < 0.001

 

 < 0.001

   < 4

 

 

 

  4–7

 

0.64 (0.47–0.88)

 

0.67 (0.43–1.05)

 

   ≥ 8

 

0.41 (0.30–0.56)

 

0.42 (0.26–0.66)

 

During the first 24 h in ICU

Oxygenation technique

1491

 

 < 0.001

 

 < 0.001

  Standard oxygen

 

 

 

  HFNC

 

1.27 (0.99–1.63)

 

0.90 (0.61–1.33)

 

  NIV

 

2.64 (1.95–3.56)

 

2.75 (1.79–4.21)

 

Cardiovascular component of the SOFA score ≥ 3

1435

1.16 (0.64–2.12)

0.630

0.75 (0.32–1.75)

0.250

Renal component of the SOFA score ≥ 3

1416

2.43 (1.69–3.49)

 < 0.001

1.81 (1.02–3.20)

0.099

PaO2/FiO2b, mmHg

1216

 

 < 0.001

 

 < 0.001

   ≤ 100

 

 

 

  101–200

 

0.68 (0.52–0.88)

 

0.58 (0.41–0.81)

 

  201–300

 

0.46 (0.29–0.72)

 

0.37 (0.20–0.68)

 

   > 300

 

0.24 (0.10–0.58)

 

0.08 (0.01–0.62)

 

Lymphocyte count < 1 × 109/L

1199

1.38 (1.06–1.80)

0.015

0.88 (0.62–1.24)

0.646

Platelet count < 150 × 109/L

1342

2.16 (1.67–2.80)

 < 0.001

2.02 (1.41–2.89)

 < 0.001

  1. HR hazard ratio, CI confidence interval, HFNC high-flow nasal cannula, NIV noninvasive ventilation, SAPS Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment, PaO2/FiO2 partial pressure of oxygen to fraction of inspired oxygen ratio
  2. aDefined as hematological malignancies, active solid tumor, or having received specific anti-tumor treatment within a year, solid organ transplant, human immunodeficiency virus, or immunosuppressants
  3. bCalculated for all patients, including those on oxygen therapy by using conversion tables provided in the online supplement